Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Ad icon
Video Content Creator
pramukag
Updated:
Sunday at 6:10 AM
Ad icon
QA Engineer Intern
pramukag
Updated:
Sunday at 6:07 AM
Ad icon
Sell your Land, House on idamata.lk for FREE
sajith.xp.pk
Updated:
Thursday at 9:03 AM
Handmade Character Soft Toys
anil1961
Updated:
Jun 23, 2026
Bodim.lk out now !
Manoj Suranga Bandara
Updated:
Jun 21, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
ElaKiri.com
News and Updates
New Cholesterol lowering jab
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 26865038" data-attributes="member: 562115"><p>A new Cholesterol lowering drug from Novartis is hailed as "Life Changing". It's been just approved in the UK. Global trials have proved that this drug safely cuts cholesterol by 50%.</p><p></p><p>The drug is "Inclisiran", and it is administered as an injection. It boosts the liver’s ability to reduce levels of low-density lipoprotein (LDL) cholesterol, known as “bad” cholesterol. This drug is deemed to a game changer.</p><p></p><p>It's a double-stranded, small interfering ribonucleic acid (siRNA), conjugated on the sense strand with triantennary N-acetylgalactosamine (GalNAc) to facilitate uptake by hepatocytes.</p><p></p><p>It's the first of a drug family that uses RNA interference to help the body remove harmful cholesterol from the bloodstream. It does this by silencing a gene called <em>PCSK9</em>, which instructs the body to produce a protein that helps regulate the amount of cholesterol in the blood. By turning off this gene, Inclisiran helps the liver absorb more LDL cholesterol from the blood and break it down.</p><p>Following a<strong> single subcutaneous</strong> administration of 284 mg inclisiran, LDL-C reduction was apparent within 14 days post-dose. <strong>Mean reductions of 49-51% for LDL-C were observed 30 to 60 days post-dose. At day 180, LDL-C levels were still reduced by approximately 53%.</strong></p><p></p><p>Inclisiran may also be a convenient, effective option for people who have not seen satisfactory reductions in their cholesterol levels with drugs called statins, as well as for people who cannot take this type of drug.</p><p></p><p>Furthermore, when inclisiran is combined with a statin, researchers predict a 75–80% reduction in cholesterol levels.</p><p></p><p>The under-the-skin jab will be administered<strong> twice annually.</strong></p></blockquote><p></p>
[QUOTE="imhotep, post: 26865038, member: 562115"] A new Cholesterol lowering drug from Novartis is hailed as "Life Changing". It's been just approved in the UK. Global trials have proved that this drug safely cuts cholesterol by 50%. The drug is "Inclisiran", and it is administered as an injection. It boosts the liver’s ability to reduce levels of low-density lipoprotein (LDL) cholesterol, known as “bad” cholesterol. This drug is deemed to a game changer. It's a double-stranded, small interfering ribonucleic acid (siRNA), conjugated on the sense strand with triantennary N-acetylgalactosamine (GalNAc) to facilitate uptake by hepatocytes. It's the first of a drug family that uses RNA interference to help the body remove harmful cholesterol from the bloodstream. It does this by silencing a gene called [I]PCSK9[/I], which instructs the body to produce a protein that helps regulate the amount of cholesterol in the blood. By turning off this gene, Inclisiran helps the liver absorb more LDL cholesterol from the blood and break it down. Following a[B] single subcutaneous[/B] administration of 284 mg inclisiran, LDL-C reduction was apparent within 14 days post-dose. [B]Mean reductions of 49-51% for LDL-C were observed 30 to 60 days post-dose. At day 180, LDL-C levels were still reduced by approximately 53%.[/B] Inclisiran may also be a convenient, effective option for people who have not seen satisfactory reductions in their cholesterol levels with drugs called statins, as well as for people who cannot take this type of drug. Furthermore, when inclisiran is combined with a statin, researchers predict a 75–80% reduction in cholesterol levels. The under-the-skin jab will be administered[B] twice annually.[/B] [/QUOTE]
Insert quotes…
Verification
Haya warak paha keeyada? (haya wadi kireema paha)
Post reply
Top
Bottom